Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(25 sites)

France

Angers - Centre Paul Papin, Angers

Angers - CHU, Angers

Avignon - CH, Avignon

Boulogne - Ambroise Paré, Boulogne

Brest - CHU, Brest

Caen - CHU, Caen

Caen - CRLCC, Caen

Créteil - CHI, Créteil

Dijon - CRLCC, Dijon

Le Mans - CHG, Le Mans

Lille - CRLCC, Lille

Marseille - APHM, Marseille

Mulhouse - GHRMSA, Mulhouse

Paris - Bichat, Paris

Paris - Hôpital Cochin, Paris

Paris - Tenon, Paris

Bordeaux - CHU, Pessac

Lyon - HCL, Pierre-Bénite

Rennes - CHU, Rennes

Rouen - Centre Henri Becquerel, Rouen

Nantes - CRLCC, Saint-Herblain

Strasbourg - CRLCC, Strasbourg

Toulouse - CHU, Toulouse

Tours - CHU, Tours

Vandoeuvre-lès-Nancy - CRLCC, Vandœuvre-lès-Nancy